Search details
1.
Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.
J Virol
; 89(16): 8304-17, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26041301
2.
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Gastroenterology
; 134(5): 1385-95, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18471515
3.
Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product.
Clin Pharmacol Drug Dev
; 7(2): 123-131, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28301098
4.
Proteomics approaches towards antigen discovery and vaccine development.
Curr Opin Mol Ther
; 4(3): 216-23, 2002 Jun.
Article
in English
| MEDLINE | ID: mdl-12139306
5.
Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination.
Vaccine
; 30(19): 2943-50, 2012 Apr 19.
Article
in English
| MEDLINE | ID: mdl-22401867
6.
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51.
Vaccine
; 29(14): 2607-12, 2011 Mar 21.
Article
in English
| MEDLINE | ID: mdl-21288804
7.
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Vaccine
; 29(35): 5925-31, 2011 Aug 11.
Article
in English
| MEDLINE | ID: mdl-21723353
8.
Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination.
PLoS Negl Trop Dis
; 4(11): e883, 2010 Nov 16.
Article
in English
| MEDLINE | ID: mdl-21103412
9.
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine.
Vaccine
; 28(12): 2397-407, 2010 Mar 11.
Article
in English
| MEDLINE | ID: mdl-20060945
10.
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
Vaccine
; 27(15): 2188-93, 2009 Mar 26.
Article
in English
| MEDLINE | ID: mdl-19200452
11.
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Vaccine
; 27(37): 5142-51, 2009 Aug 13.
Article
in English
| MEDLINE | ID: mdl-19559112
12.
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.
Vaccine
; 26(48): 6151-6, 2008 Nov 11.
Article
in English
| MEDLINE | ID: mdl-18804132
13.
Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.
Biol Chem
; 389(5): 551-9, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18953722
14.
Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches.
Expert Rev Vaccines
; 6(4): 605-15, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17669013
15.
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
Vaccine
; 25(37-38): 6793-806, 2007 Sep 17.
Article
in English
| MEDLINE | ID: mdl-17686555
16.
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.
Vaccine
; 24(20): 4343-53, 2006 May 15.
Article
in English
| MEDLINE | ID: mdl-16581161
17.
Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis.
Proteomics
; 2(5): 580-90, 2002 May.
Article
in English
| MEDLINE | ID: mdl-11987132
18.
Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma.
Int J Cancer
; 97(2): 217-24, 2002 Jan 10.
Article
in English
| MEDLINE | ID: mdl-11774267
19.
IC51: a new investigational Japanese encephalitis vaccine. Dr Christoph Klade speaks to Duc Le, editor.
Expert Rev Vaccines
; 7(8): 1139-40, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18844587
Results
1 -
19
de 19
1
Next >
>>